ES2356257T3 - Proceso para la síntesis del 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenoamina. - Google Patents

Proceso para la síntesis del 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenoamina. Download PDF

Info

Publication number
ES2356257T3
ES2356257T3 ES06772448T ES06772448T ES2356257T3 ES 2356257 T3 ES2356257 T3 ES 2356257T3 ES 06772448 T ES06772448 T ES 06772448T ES 06772448 T ES06772448 T ES 06772448T ES 2356257 T3 ES2356257 T3 ES 2356257T3
Authority
ES
Spain
Prior art keywords
lower alkyl
phenyl
compound
formula
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06772448T
Other languages
English (en)
Spanish (es)
Inventor
Joseph Mckenna
Wen-Chung Shieh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Application granted granted Critical
Publication of ES2356257T3 publication Critical patent/ES2356257T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES06772448T 2005-06-09 2006-06-07 Proceso para la síntesis del 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenoamina. Active ES2356257T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68897705P 2005-06-09 2005-06-09
US688977P 2005-06-09
US705590P 2005-08-04

Publications (1)

Publication Number Publication Date
ES2356257T3 true ES2356257T3 (es) 2011-04-06

Family

ID=39449465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06772448T Active ES2356257T3 (es) 2005-06-09 2006-06-07 Proceso para la síntesis del 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenoamina.

Country Status (3)

Country Link
CN (1) CN101184748B (zh)
ES (1) ES2356257T3 (zh)
ZA (1) ZA200709621B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086913A1 (es) * 2011-06-14 2014-01-29 Novartis Ag 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]-amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluoro-metil)-fenil]-benzamida amorfa, forma de dosificacion que la contiene y metodo para prepararlas
CN103275068A (zh) * 2013-05-23 2013-09-04 苏州明锐医药科技有限公司 尼洛替尼的制备方法
CN103254175A (zh) * 2013-05-23 2013-08-21 苏州明锐医药科技有限公司 尼洛替尼的制备方法
CN106496193A (zh) * 2016-09-13 2017-03-15 福格森（武汉）生物科技股份有限公司 一种高纯度尼罗替尼的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN101184748B (zh) 2011-09-28
ZA200709621B (en) 2008-11-26
CN101184748A (zh) 2008-05-21

Similar Documents

Publication Publication Date Title
EP1924574B1 (en) Process for the syntesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine
ES2706745T3 (es) Compuestos de aminopiridazinona como inhibidores de proteína cinasa
EP3445357B1 (en) Bifunctional molecules for degradation of egfr and methods of use
ES2897910T3 (es) Derivados bipirazolilo útiles para el tratamiento de enfermedades autoinmunitarias
ES2729958T3 (es) Método de producción de compuesto heterocíclico que contiene nitrógeno e intermedio de dicho compuesto heterocíclico que contiene nitrógeno
ES2356257T3 (es) Proceso para la síntesis del 5-(metil-1h-imidazol-1-il)-3-(trifluorometil)-bencenoamina.
AU2020292664B2 (en) Fused ring compound as FGFR and VEGFR dual inhibitor
BRPI0712787A2 (pt) processo para preparar um composto, e, composto
KR101896924B1 (ko) 신규한 항암제
ES2309518T3 (es) Compuestos de diaminopirroloquinazolinas como inhibidores de la proteina tirosina fosfatasa.
ES2955554T3 (es) Proceso para producir un derivado de purinona
CN110028502B (zh) 一种激酶抑制剂类药物中间体的制备方法
ES2725881T3 (es) Nuevos derivados de imidazolidin-2,4-diona
ES2359953T3 (es) Derivados de pirimidina como inhibidores de la fosfatidilinositol-3-kinasa.
CN115340499A (zh) Bcl-xl抑制剂及其用途
BR102016029685A2 (pt) compostos heteroaromáticos como inibidores de btk
CN104072498A (zh) （R）-N-[5-(2-甲氧基-2-苯基乙酰基)-1,4,5,6-四氢吡咯并[3,4-c]吡唑-3-基]-4-(4-甲基哌嗪-1-基)苯甲酰胺的合成方法